Global Advisory Committee on Vaccine Safety review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine
Date Time Share Global Advisory Committee on Vaccine Safety review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine A very rare new type of adverse event called Thrombosis with Thrombocytopenia Syndrome (TTS), involving unusual and severe blood clotting events associated with low platelet counts, has been reported after vaccination with COVID-19 Vaccines Vaxzevria and Covishield. A specific case definition for TTS is being developed by the Brighton Collaboration 1. This will assist in identifying and evaluating reported TTS events and aid in suppo...
Source: miragenews.com